These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 16912181)

  • 41. Cadherins in Wilms' tumor: E-cadherin expression despite absence of WT1.
    Baudry D; Cabanis MO; Patte C; Zucker JM; Pein F; Fournet JC; Sarnacki S; Junien C; Jeanpierre C
    Anticancer Res; 2003; 23(1A):475-8. PubMed ID: 12680252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.
    Mrowka C; Schedl A
    J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S106-15. PubMed ID: 11065340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. WT1 splicing alterations in Wilms' tumors.
    Baudry D; Hamelin M; Cabanis MO; Fournet JC; Tournade MF; Sarnacki S; Junien C; Jeanpierre C
    Clin Cancer Res; 2000 Oct; 6(10):3957-65. PubMed ID: 11051244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of possible WT1 RNA processing in primary Wilms tumors.
    Gunning KB; Cohn SL; Tomlinson GE; Strong LC; Huff V
    Oncogene; 1996 Sep; 13(6):1179-85. PubMed ID: 8808692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour.
    Baudry D; Faussillon M; Cabanis MO; Rigolet M; Zucker JM; Patte C; Sarnacki S; Boccon-Gibod L; Junien C; Jeanpierre C
    Oncogene; 2002 Aug; 21(36):5566-73. PubMed ID: 12165855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetics of Wilms' tumor.
    Coppes MJ; Egeler RM
    Semin Urol Oncol; 1999 Feb; 17(1):2-10. PubMed ID: 10073400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1.
    Wagner N; Wagner KD; Xing Y; Scholz H; Schedl A
    J Am Soc Nephrol; 2004 Dec; 15(12):3044-51. PubMed ID: 15579507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Wilms' tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action?
    Olszewski M; Huang W; Chou PM; Duerst R; Kletzel M
    Cytotherapy; 2005; 7(1):57-61. PubMed ID: 16040384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation.
    Caldon CE; Lee CS; Sutherland RL; Musgrove EA
    Oncogene; 2008 Jan; 27(1):126-38. PubMed ID: 17599043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identical genetic changes in different histologic components of Wilms' tumors.
    Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
    J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.
    Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS
    EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Wilms' tumour: connecting tumorigenesis and organ development in the kidney.
    Rivera MN; Haber DA
    Nat Rev Cancer; 2005 Sep; 5(9):699-712. PubMed ID: 16110318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High frequency of loss of allelic integrity at Wilms' tumor suppressor gene-1 locus in advanced breast tumors associated with aggressiveness of the tumor.
    Gupta S; Joshi K; Wig JD; Arora SK
    Indian J Cancer; 2009; 46(4):303-10. PubMed ID: 19749460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calcineurin a-binding protein, a novel modulator of the calcineurin-nuclear factor of activated T-cell signaling pathway, is overexpressed in wilms' tumors and promotes cell migration.
    Nguyen AH; Béland M; Gaitan Y; Bouchard M
    Mol Cancer Res; 2009 Jun; 7(6):821-31. PubMed ID: 19531566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Molecular genetics of Wilms' tumor].
    Papezová M; Mares J; Goetz P
    Cas Lek Cesk; 2001 Jun; 140(11):323-7. PubMed ID: 11431850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma.
    Masuda M; Ruan HY; Ito A; Nakashima T; Toh S; Wakasaki T; Yasumatsu R; Kutratomi Y; Komune S; Weinstein IB
    Oral Oncol; 2007 Sep; 43(8):785-90. PubMed ID: 17169602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two molecular subgroups of Wilms' tumors with or without WT1 mutations.
    Schumacher V; Schuhen S; Sonner S; Weirich A; Leuschner I; Harms D; Licht J; Roberts S; Royer-Pokora B
    Clin Cancer Res; 2003 Jun; 9(6):2005-14. PubMed ID: 12796362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy.
    Lehe C; Ghebeh H; Al-Sulaiman A; Al Qudaihi G; Al-Hussein K; Almohareb F; Chaudhri N; Alsharif F; Al-Zahrani H; Tbakhi A; Aljurf M; Dermime S
    Cancer Res; 2008 Aug; 68(15):6350-9. PubMed ID: 18676860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
    Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
    J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.